Journals / ARTEMİS / 2004 / Cilt: 5 - Sayı: 3

Preeklampside koagülasyon profilinin gerekliliği

Necessity of coagulation profile in preeclampsia

Journal
ARTEMİS
Pages
217–219
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Overall, increased LDH level has a sensitivity of 85.7% (6/7), specificity of 59.3% (67/113), PPV of 11.5% (6/52) and NPV of 98.5% (67/68) in the setting of a prolonged PT and or aPTT.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: To evaluate the clinical utility of the currently used laboratory studies, especially coagulation tests, in the evaluation of the patients with preeclampsia.
📊
Key Findings & Data:Materials and Methods: We evaluated the coagulation profile, platelet count, serum levels of lactate dehyrogenase (LDH) and transaminases of 120 preeclamptic patients (October 1999-March 2000).
💡
Conclusion & Impact:Overall, increased LDH level has a sensitivity of 85.7% (6/7), specificity of 59.3% (67/113), PPV of 11.5% (6/52) and NPV of 98.5% (67/68) in the setting of a prolonged PT and or aPTT.
🔬Design:Research Article
📍Scope:2000 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: To evaluate the clinical utility of the currently used laboratory studies, especially coagulation tests, in the evaluation of the patients with preeclampsia. Materials and Methods: We evaluated the coagulation profile, platelet count, serum levels of lactate dehyrogenase (LDH) and transaminases of 120 preeclamptic patients (October 1999-March 2000). Results: LDH levels were above 240 U/ml in 52 patients. Thrombocytopenia and elevated liver enzymes were observed in 32 patients. The coagulation profile was within the normal limits in 68 patients. The sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of LDH levels in prediction of prolonged aPTT is 100% (2/2), 57.6% (68/118), 3.8% (2/52) and 100% (68/68) respectively. The sensitivity, specificity, PPV and NPV of an abnormal LDH in prediction of prolonged PT are 83.3% (5/6), 58.8% (67/114), 9.2% (5/52) and 98.5% (67/68) respectively. Overall, increased LDH level has a sensitivity of 85.7% (6/7), specificity of 59.3% (67/113), PPV of 11.5% (6/52) and NPV of 98.5% (67/68) in the setting of a prolonged PT and or aPTT. Conclusion: The coagulation profile is not a necessary test in the initial workup of preeclamptic patients. In patients with LDH levels

Özet

Amaç: Preeklampsili hastaların değerlendirilmesinde günümüzde kullanılan laboratuvar testlerinin, özellikle koagülasyon testlerinin, klinik yararını araştırmak. Materyal ve Metot: 120 preeklamptik hastanın koagülasyon profili, trombosit sayısı, serum LDL düzeyleri ve transaminazlarına bakıldı (Ekim 1999-Mart 2000). Sonuçlar: Serum LDH seviyeleri 52 hastada 240 U/ml'den yüksekti. Trombositopeniye ve yükselmiş transaminazlara 32 hastada rastlandı. Koagülasyon profili 68 hastada normaldi. LDH'nin uzamış aPTT'yi tespit etmedeki duyarlılığı, özgüllüğü, pozitif tahmin değeri (PPV) ve negatif tahmin değeri (NPV) sırasıyla %100 (2/2), 5%7.6 (68/118), %3.8 (2/52) ve%100 (68/68) olarak bulundu. Uzamış PT'yi tespit etmek için bu değerler sırasıyla, %83.3 (5/6), %58.8 (67/114), %9.2 (5/52) ve %98.5 (67/68) olarak bulundu. Genel olarak LDH'nin uzamış aPTT ve/veya PT'yi tespit etmedeki duyarlılığı, özgüllüğü, PPV'si ve NPV'si sırasıyla 85.7% (6/7), 59.3% (67/113), 11.5% (6/52) ve 98.5% (67/68) olarak tespit edildi. Tartışma: Koagülasyon profili preeklamptik hastaların ilk değerlendirmesinde mutlaka gerekli olan bir test değildir. LDH'si 240 U/ml'nin altında olan hastalarda koagülasyon profiline bakılması maliyet etkinlik açısından uygun değildir.

🔖

Cite This Article

AYTAN, H., TUNCAY, G., KAZIMOĞLU, U., ÖZKUL, M. S. A., ÜNLÜ, B. S., ÇELEN, Ş., KALYONCU, Ş., ÖZEL, M. (2022). Preeklampside koagülasyon profilinin gerekliliği. ARTEMİS, Cilt: 5 - Sayı: 3, 217–219. https://ajindex.com/articles/449505

References (8)

  1. Sibai BM. Preeclampsia-Lclampsia: Current Problems in Obstetrics Gynecology and Fertility 1990;13:1-45
  2. Report of the National High Blood Pressure Lducalion Program Working Group Report on High Blood Pressure in Pregnancy Am J Obslel Gynecol 2000:183:1-22
  3. Garovie VD, Hypertension in Pregnancy: Diagnosis and Treatment. Mayo Clin proc 2000:75:1071-1076
  4. William M. Barron. MD. Paul Heckerling. MD. Judith Hibbard, MD. Susan Fisher, phD. Reducing Unnecessary Coagulation Testing in Hypertensive Disorders of Pregnancy. Obstetrics and Gynecology. 1999:94:364-70
  5. Line Leduc MD. James M. Wheeler. MD. MPH, Brian Kirshon, MD, Patricia mitchell,MD. Coagulation Profile in Severe Preeclampsia. Obstetrics and Gynecology. 1902:79:14-18
  6. Sharma SK. Philip J, Whitten CW. Padakandla LB. Landers DF. Assessment of Changes in Coagulations in Parturients With Preeclampsia Using Thromboelastography. Anesthesiology 1999;90(2):385-90
  7. Ralph L. Kramer. MD, Luis A. Izquierdo,MD. George J. Gilson. MD.Luis B. Curet MD. Preeclamptic Labbs for Evaluating Hypertension in Pregnancy. The Journal of Reproductive Medicine. 1997:42:223-28
  8. Rinhart BK, Terrone DA. May WL. Magon EF, Isler CM. Martin JN Jr. Changes in platelet count predicts eventual maternal outcome with syndrome of hemolysis, elevated liver enzymes and low platelet count. J Maternal Fetal Med. 2001:10( l):28-34.